CTRI/2024/07/071678尚未招募Unknown
Safety and efficacy of oral itraconazole versus oral itraconazole with isotretinoin in chronic and recurrent superficial dermatophytosis A randomized trial - NI
Bhagat Phool Singh Govt. Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All adult patients in the age group of 18 to 60 years who are clinically
- •diagnosed with tinea corporis and cruris with more than 20% BSA and duration of infection is
- •more than 6 months with KOH positive preparation attending the dermatology Out Patient
- •Department of BPS GMC(W) Khanpur Kalan, Sonepat.
排除标准
- •1) Patients with tinea capitis and onychomycosis.
- •2) Patients with tinea for less than 6 months or limited tinea involving less than 20% of body
- •surface area.
- •3) Any patient who took itraconazole for tinea in last one year.
- •4) Patients with liver diseases, renal diseases and ischaemic heart diseases.
- •5) Patients with hyperlipidaemia.
- •6) Patients currently on immunosuppressive and corticosteroid therapy.
- •7) Pregnant and lactating women and females of reproductive age who cannot or refused to take
- •contraceptive pills
研究者
相似试验
尚未招募
不适用
To compare the effectiveness of oral itraconazole with low dose and high dose isotretinoin in the treatment of tineaCTRI/2019/06/019600Department of dermatology
进行中（未招募）
1 期
Itraconazole as treatment for severe nose bleeding in patients with hereditary hemorrhagic telangiectasiaSevere epistaxis in patients with Hereditary Hemorrhagic Telangiectasia also known as Rendu-Osler-Weber diseaseMedDRA version: 20.0Level: LLTClassification code 10031132Term: Osler-Weber-Rendu diseaseSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 100000004850EUCTR2017-003272-31-NLSt. Antonius Ziekenhuis25
已完成
2 期
Efficacy and safety of oral itraconazole in the reduction of epistaxis severity in hereditary hemorrhagic telangiectasiahereditary hemorrhagic telangiectasiaRendu-Osler-Weber disease100075101004704310047075NL-OMON46365Sint Antonius Ziekenhuis25
尚未招募
3 期
Efficacy and safety of itraconazole, SUBA-itraconazole and voriconazole in Recalcitrant Dermatophytosis.CTRI/2024/05/066681I
已完成
不适用
se of Itraconazole oral solution in Children with Fungal InfectioCTRI/2019/05/019139Dr Ramesh Bhat M30